Project CBD

MARCH 21, 2023

Auditory & Other Symptoms The survey, whose findings were published in February 2023 in the Journal of Otolaryngology – Head & Neck Surgery 1 evaluated cannabis perceptions and consumption among 45 adult tinnitus patients randomly selected and recruited from an outpatient ear, nose, and throat clinic in Ontario, Canada.

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

Veriheal

JANUARY 26, 2023

Using Cannabis for Bipolar Disorder Symptoms Is Also Supported by Early Research Earlier groundbreaking research has also suggested cannabis consumption may be associated with improved bipolar disorder symptoms for patients. Thus, this groundbreaking study laid the foundation for understanding how cannabinoids can support mental health.

Treatment 98

Treatment Cannabinoids Conditions Pharmaceutical 98

Cannabis Law Report

JANUARY 23, 2022

At current, transplant treatments are hindered by our understanding of the immune response of those receiving treatments. More than 25,000 hematopoietic stem cell transplantations (HSCTs) are performed each year for the treatment of lymphoma, leukemia, immune-de?ciency Mol Pharmacol, 70(3), pp. doi: 10.1124/MOL.106.023937.

Research and Development 52

Research and Development Wellness and Beauty Patients CBD 52

Kind Meds (Cannabis Education Blog)

SEPTEMBER 13, 2022

CBD and THC are the two foremost cannabinoid compounds available in products from smokeable flower to edibles, topicals, and more. However, CBD is another critical cannabinoid that doesn’t get you high. Usually, people will benefit from experimenting for a while to determine which cannabinoid is best for them. Is cannabis safe?

THC 72

THC CBD Nerve Pain Terpenes 72

CannaMD

OCTOBER 7, 2019

While scientists are still searching for a definitive explanation, researchers with Cannabis and Cannabinoid Research have an interesting theory. Analyzing a collection of similar research, Cannabis and Cannabinoid Research summarizes: Across these studies, on average, cannabis users consumed an additional 834?calories/day

Marijuana 105

Marijuana Cannabinoids Patients Conditions 105

Greencamp

JANUARY 5, 2019

“An involvement of the endocannabinoid system with schizophrenia is supported both by the epidemiological observation that increased cannabis use is associated with a heightened risk for schizophrenia and that acute consumption of cannabis or synthetic cannabinoids can elicit psychotic symptoms in susceptible individuals.”.

Research and Development 96

Research and Development Marijuana History Patients 96

Greencamp

AUGUST 16, 2018

Exploring the available research on ALS and cannabinoids. The CBD cannabinoid is proven to be an exceptional seizure-controlling agent for epilepsy patients, and also shows great promise for treating Parkinson’s , Alzheimer’s and Multiple Sclerosis. The first study I will reference is from 2006, conducted on mice.

Strains 94

Strains Cannabinoids Research and Development Indica 94